HIV11: Stribild Matches Efficacy and Tolerability of Atripla or Boosted Atazanavir at 96 Weeks
There are 1 comment on the HIV and Hepatitis story from Nov 27, 2012, titled HIV11: Stribild Matches Efficacy and Tolerability of Atripla or Boosted Atazanavir at 96 Weeks. In it, HIV and Hepatitis reports that:The Stribild single-tablet-regimen -- formerly dubbed the Quad -- demonstrated "robust and durable" efficacy and continued to be well-tolerated through 96 weeks, according to findings from 2 studies presented at the 11th International Congress on Drug Therapy in HIV Infection this month in Glasgow.
Join the discussion below, or Read more at HIV and Hepatitis.
#1 Jan 15, 2013
Learn more about the HIV/AIDS drug Atripla at http://www.rxwiki.com/atripla
Add your comments below
|Fight over $1,100 hepatitis C pills awaits next... (Dec '14)||Dec '14||reneir880||1|
|Gilead Sciences Under Investigation for Over-Ch... (Jul '14)||Jul '14||Chris||1|
|FDA Panel OKs Truvada for HIV Prevention (May '12)||May '14||Sheldon||6|
|$1,000 hepatitis C pill a tough miracle to swallow (May '14)||May '14||Hep C Veterans||1|
|Divide over HIV prevention drug Truvada persists (Apr '14)||Apr '14||juls||2|
|FDA advisors back new Hepatitis C drug (Oct '13)||Oct '13||WARNING FDA APPROVED||1|
|Gilead's Sofosbuvir for Hepatitis C Meets Prima... (Feb '13)||Feb '13||Axel||1|
Find what you want!
Search Gilead Sciences Forum Now
Copyright © 2016 Topix LLC